Table 2 Clinical parameters of breast cancer cases.

From: Impending role of inflammatory markers and their specificity and sensitivity in breast cancer patients

 

Cases (n = 498)

Cases (%)

Breast involved

 Left

377

75.702

 Right

121

24.297

ER status

 ER + 

423

84.939

 ER−

75

15.060

PR status

 PR + 

431

86.546

 PR−

67

13.453

HER2 status

 HER2 + 

434

87.148

 HER2−

64

12.851

TNBC

 Yes

209

41.967

 No

289

58.032

TNM staging

 I

88

17.670

 II

102

20.481

 III and IV

308

61.847

Tumor grade

 Grade I

0.00

0.0000

 Grade II

176

35.341

 Grade III

322

64.658

Type of tumor

 Invasive ductal carcinoma

304

61.044

 Invasive lobular carcinoma

85

17.068

 Medullary carcinoma

58

11.646

 Malignant phyllodes

32

6.425

 Papillary carcinoma

19

3.815

  1. PR progesterone receptor, HER2 human epidermal growth factor receptor 2, TNM is tumor node and metastasis (grading system).
  2. ER estrogen receptor.
Back to article page